[AVTE] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
25-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -4.34%
YoY- -35.89%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 136 0 0 0 0 0 -
PBT -23,186 -20,357 -19,563 -19,025 -16,520 -14,997 -13,588 42.74%
Tax 0 56 -25 -1,312 -1,119 25 -564 -
NP -23,186 -20,413 -19,563 -19,025 -15,401 -15,022 -13,024 46.83%
Tax Rate - - - - - - - -
Total Cost 23,186 20,549 19,563 19,025 15,401 15,022 13,024 46.83%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -15,009.56 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.83 -0.74 -0.71 -0.76 -0.62 -0.61 -0.53 34.81%
EPS Diluted -0.83 -0.74 -0.71 -0.76 -0.62 -0.61 -0.53 34.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.